BioNet Holding GmbH is a venture capital firm in Martinsried that focuses on coordination, financing and management of biotech or life science companies based in Germany. Founded in 1997 in Martinsried, Bayern, the firm invests in series B rounds. The notable investment portfolio of BioNet Holding GmbH includes Scil Proteins and Scout Analytics.
The company can provide investment management services through BioNet Holding GmbH's subsidiaries. One of the major concerns for BioNet Holding is Osteoarthritis (OA), and aims to change the standard of care for reversing the disease process found in OA. The company invests in developments towards reduction of joint inflammation, pain relief, and cartilage regeneration.
Christian Nafe, Dipl.-Kfm.
Dr. Stefan Engelhorn
Documentaries, videos and podcasts